Cargando…
The alkaloids. Volume 37, Antitumor bisindole alkaloids from catharanthus roseus (L) /
The Alkaloids: Antitumor Bisindole Alkaloids from Catharanthus roseus (L.) V37.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego ; London :
Academic Press,
�1990.
|
| Colección: | Alkaloids. ;
v. 37 |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ma 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn646759078 | ||
| 003 | OCoLC | ||
| 005 | 20231117033256.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 840822s1990 caua ob 001 0 eng d | ||
| 040 | |a E7B |b eng |e pn |c E7B |d OCLCQ |d OPELS |d OCLCQ |d OCLCF |d OCLCQ |d DEBSZ |d VLY |d OCLCO |d OCL |d OCLCQ |d OCLCO | ||
| 019 | |a 1162113451 | ||
| 020 | |a 012469537X |q (electronic bk.) | ||
| 020 | |a 9780124695375 |q (electronic bk.) | ||
| 020 | |a 1281749478 | ||
| 020 | |a 9781281749475 | ||
| 020 | |a 9786611749477 | ||
| 020 | |a 6611749470 | ||
| 020 | |a 0080865615 | ||
| 020 | |a 9780080865614 | ||
| 035 | |a (OCoLC)646759078 |z (OCoLC)1162113451 | ||
| 050 | 4 | |a QD421.A1 |b A4337 1990eb | |
| 082 | 0 | 4 | |a 572/.549 |2 23 |
| 245 | 0 | 4 | |a The alkaloids. |n Volume 37, |p Antitumor bisindole alkaloids from catharanthus roseus (L) / |c edited by Arnold Brossi, Matthew Suffness. |
| 260 | |a San Diego ; |a London : |b Academic Press, |c �1990. | ||
| 300 | |a 1 online resource (ix, 250 pages) : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Alkaloids. ; |v v. 37 | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; The Alkaloids, Volume 37; Copyright Page; CONTENTS; Contributors; Preface; Chapter 1. Isolation, Structure Elucidation, and Biosynthesis of the Bisindole Alkaloids of Catharanthus; I. Introduction; II. Structure Elucidation and Spectroscopy; III. Biosynthesis; IV. Summary; References; Chapter 2. Syntheses of Vinblastine-Type Alkaloids; I. Introduction; II. Hydroxyalkylindole Route; III. Chloroindolenine Route; IV. �-Carboline Coupling; V. Biomimetic Approach; VI. New Strategies for Generation of C-16'-C-14' PARF Relative Stereochemistry; References | |
| 505 | 8 | |a Chapter 3. Functional Hot Spot at the C-20' Position of VinblastineI. Introduction; II. C-20' Modifications; III. Molecular Constraints of Congener Activity; IV. Conclusions; References; Chapter 4. Medicinal Chemistry of Bisindole Alkaloids From Catharanthus; I. Introduction; II. Pharmacology; III. Physicochemical Considerations; IV. Naturally Occurring Bisindole Alkaloids from Catharanthus; V. Modifications of the Upper Half (Velbanamine Portion) of Bisindole Alkaloids; VI. Modifications of the Lower Half (Vindoline Portion) of Bisindole Alkaloids | |
| 505 | 8 | |a VII. Multiple Modifications: 4'-EpideoxyvincristineVIII. New Concepts in Medicinal Chemistry of Bisindole Alkaloids; IX. Conclusions; References; Chapter 5. Pharmacology of Antitumor Bisindole Alkaloids from Catharanthus; I. Introduction; II. Biochemical Pharmacology; III. Cellular Pharmacology; IV. Preclinical Pharmacology; V. Preclinical Toxicology; VI. Clinical Pharmacology; VII. Clinical Toxicology; References; Chapter 6. The Therapeutic Use of Bisindole Alkaloids from Catharanthus; I. History of Therapeutic Use; II. Current Therapeutic Use; III. Toxicity; IV. Mechanism of Action | |
| 505 | 8 | |a V. Drug ResistanceReferences; Cumulative Index of Titles; Index | |
| 520 | |a The Alkaloids: Antitumor Bisindole Alkaloids from Catharanthus roseus (L.) V37. | ||
| 546 | |a English. | ||
| 650 | 0 | |a Alkaloids |x Physiological effect. | |
| 650 | 0 | |a Antineoplastic agents. | |
| 650 | 0 | |a Antimitotic agents. | |
| 650 | 6 | |a Alcalo�ides |x Effets physiologiques. |0 (CaQQLa)201-0097058 | |
| 650 | 6 | |a Anticanc�ereux. |0 (CaQQLa)201-0004692 | |
| 650 | 7 | |a Antimitotic agents |2 fast |0 (OCoLC)fst00810570 | |
| 650 | 7 | |a Alkaloids |x Physiological effect |2 fast |0 (OCoLC)fst00805401 | |
| 650 | 7 | |a Antineoplastic agents |2 fast |0 (OCoLC)fst00810595 | |
| 700 | 1 | |a Brossi, Arnold. | |
| 700 | 1 | |a Suffness, Matthew. | |
| 776 | |z 0-12-469537-X | ||
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780124695375 |z Texto completo |